Viemed Healthcare, Inc.

NasdaqCM:VMD Stock Report

Market Cap: US$324.3m

Viemed Healthcare Future Growth

Future criteria checks 4/6

Viemed Healthcare is forecast to grow earnings and revenue by 32.5% and 12.9% per annum respectively while EPS is expected to grow by 30.3% per annum.

Key information

32.5%

Earnings growth rate

30.3%

EPS growth rate

Healthcare earnings growth17.4%
Revenue growth rate12.9%
Future return on equityn/a
Analyst coverage

Low

Last updated08 Nov 2024

Recent future growth updates

Recent updates

When Should You Buy Viemed Healthcare, Inc. (NASDAQ:VMD)?

Apr 11
When Should You Buy Viemed Healthcare, Inc. (NASDAQ:VMD)?

These 4 Measures Indicate That Viemed Healthcare (NASDAQ:VMD) Is Using Debt Safely

Mar 07
These 4 Measures Indicate That Viemed Healthcare (NASDAQ:VMD) Is Using Debt Safely

Viemed Healthcare: Comments On Q2 Earnings

Aug 25

Viemed Healthcare Q2 2022 Earnings Preview

Aug 02

Viemed Healthcare: New Bullish Trend Has Just Begun

Dec 29

Viemed Healthcare, Inc. 2021 Q1 - Results - Earnings Call Presentation

May 06

Viemed Healthcare EPS misses by $0.01, revenue in-line

May 03

Strong Execution By Insider-Owners Ensures Viemed's Growth

Jan 11

Viemed Healthcare EPS misses by $0.02, beats on revenue

Nov 05

Earnings and Revenue Growth Forecasts

NasdaqCM:VMD - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202628721N/AN/A1
12/31/202525316N/AN/A3
12/31/202422411N/AN/A3
9/30/202421410437N/A
6/30/20242069838N/A
3/31/202419410836N/A
12/31/2023183101945N/A
9/30/202317091640N/A
6/30/202315671134N/A
3/31/20231466731N/A
12/31/20221396528N/A
9/30/20221338529N/A
6/30/20221279026N/A
3/31/20221219325N/A
12/31/20211179322N/A
9/30/202111610220N/A
6/30/2021120111022N/A
3/31/2021136292939N/A
12/31/2020131322235N/A
9/30/2020122292637N/A
6/30/2020108292435N/A
3/31/20208611219N/A
12/31/2019809619N/A
9/30/2019769720N/A
6/30/2019738819N/A
3/31/20196891622N/A
12/31/201864101622N/A
9/30/20186071115N/A
6/30/2018569N/A13N/A
3/31/2018518N/A9N/A
12/31/2017478N/A12N/A
9/30/20174311N/A14N/A
12/31/2016311N/A6N/A
12/31/20153810N/A10N/A
12/31/2014239N/A8N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: VMD's forecast earnings growth (32.5% per year) is above the savings rate (2.6%).

Earnings vs Market: VMD's earnings (32.5% per year) are forecast to grow faster than the US market (14.8% per year).

High Growth Earnings: VMD's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: VMD's revenue (12.9% per year) is forecast to grow faster than the US market (8.8% per year).

High Growth Revenue: VMD's revenue (12.9% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if VMD's Return on Equity is forecast to be high in 3 years time

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/06 05:20
End of Day Share Price 2025/02/06 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Viemed Healthcare, Inc. is covered by 5 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Doug CooperBeacon Securities Limited
Vadim MerkulovFreedom Broker
Ilya ZubkovFreedom Broker